Authors
Loading...
Systematic review and meta-analysis finds a 34.3% Pseudomonas aeruginosa prevalence in cystic fibrosis patients, highlighting colistin and ticarcillin as optimal choices against resistance.
Rastegar-Kashkouli et al. (2024) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: